367 related articles for article (PubMed ID: 27567086)
41. Subsequent malignancies and their effect on survival in patients with retinoblastoma.
Shinohara ET; DeWees T; Perkins SM
Pediatr Blood Cancer; 2014 Jan; 61(1):116-9. PubMed ID: 23918737
[TBL] [Abstract][Full Text] [Related]
42. Incidence of new tumor formation in patients with hereditary retinoblastoma treated with primary systemic chemotherapy: is there a preventive effect?
Wilson MW; Haik BG; Billups CA; Rodriguez-Galindo C
Ophthalmology; 2007 Nov; 114(11):2077-82. PubMed ID: 17628684
[TBL] [Abstract][Full Text] [Related]
43. Characteristics and Survival Outcomes of Second Primary Cancers in Long-term Retinoblastoma Survivors.
Zhao NO; Daewoo P; El-Hadad C; Debnam JM; Ning J; Esmaeli B
Asia Pac J Ophthalmol (Phila); 2021 Jan; 10(4):366-372. PubMed ID: 33481394
[TBL] [Abstract][Full Text] [Related]
44. Long-term visual outcomes in intraocular retinoblastoma with eye preservation.
Batra A; Pushker N; Venkatesh P; Arora T; Tewari R; Bakhshi S
Clin Transl Oncol; 2016 Oct; 18(10):1034-8. PubMed ID: 26781471
[TBL] [Abstract][Full Text] [Related]
45. Survival and ocular preservation in a long-term cohort of Japanese patients with retinoblastoma.
Ueda T; Koga Y; Yoshikawa H; Tanabe M; Yamana K; Oba U; Nakashima K; Ono H; Ichimura T; Hasegawa S; Kato W; Kobayashi T; Nakayama H; Sakai Y; Yoshitake T; Ohga S; Oda Y; Suzuki S; Sonoda KH; Ohga S
BMC Pediatr; 2020 Jan; 20(1):37. PubMed ID: 31992242
[TBL] [Abstract][Full Text] [Related]
46. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
Schaapveld M; Aleman BM; van Eggermond AM; Janus CP; Krol AD; van der Maazen RW; Roesink J; Raemaekers JM; de Boer JP; Zijlstra JM; van Imhoff GW; Petersen EJ; Poortmans PM; Beijert M; Lybeert ML; Mulder I; Visser O; Louwman MW; Krul IM; Lugtenburg PJ; van Leeuwen FE
N Engl J Med; 2015 Dec; 373(26):2499-511. PubMed ID: 26699166
[TBL] [Abstract][Full Text] [Related]
47. Intensive multimodality therapy for patients with stage 4a metastatic retinoblastoma.
Dunkel IJ; Khakoo Y; Kernan NA; Gershon T; Gilheeney S; Lyden DC; Wolden SL; Orjuela M; Gardner SL; Abramson DH
Pediatr Blood Cancer; 2010 Jul; 55(1):55-9. PubMed ID: 20486171
[TBL] [Abstract][Full Text] [Related]
48. Third (fourth and fifth) nonocular tumors in survivors of retinoblastoma.
Abramson DH; Melson MR; Dunkel IJ; Frank CM
Ophthalmology; 2001 Oct; 108(10):1868-76. PubMed ID: 11581064
[TBL] [Abstract][Full Text] [Related]
49. Ewing's sarcoma as second malignancy following a short latency in unilateral retinoblastoma.
Tahasildar N; Goni V; Bhagwat K; Tripathy SK; Panda BB
J Orthop Traumatol; 2011 Sep; 12(3):167-71. PubMed ID: 21826516
[TBL] [Abstract][Full Text] [Related]
50. Retinoblastoma: diagnosis and management--the UK perspective.
Jenkinson H
Arch Dis Child; 2015 Nov; 100(11):1070-5. PubMed ID: 25940424
[TBL] [Abstract][Full Text] [Related]
51. Risk of third malignancies and death after a second malignancy in retinoblastoma survivors.
Marees T; van Leeuwen FE; Schaapveld M; Imhof SM; de Boer MR; Kors WA; Ringens PJ; Moll AC
Eur J Cancer; 2010 Jul; 46(11):2052-8. PubMed ID: 20400293
[TBL] [Abstract][Full Text] [Related]
52. Second primary malignancies in retinoblastoma patients treated with intra-arterial chemotherapy: the first 10 years.
Habib LA; Francis JH; Fabius AW; Gobin PY; Dunkel IJ; Abramson DH
Br J Ophthalmol; 2018 Feb; 102(2):272-275. PubMed ID: 28600304
[TBL] [Abstract][Full Text] [Related]
53. Second malignant neoplasms following chemoreduction with carboplatin, etoposide, and vincristine in 245 patients with intraocular retinoblastoma.
Turaka K; Shields CL; Meadows AT; Leahey A
Pediatr Blood Cancer; 2012 Jul; 59(1):121-5. PubMed ID: 21826785
[TBL] [Abstract][Full Text] [Related]
54. Retinoblastoma.
Rodriguez-Galindo C; Orbach DB; VanderVeen D
Pediatr Clin North Am; 2015 Feb; 62(1):201-23. PubMed ID: 25435120
[TBL] [Abstract][Full Text] [Related]
55. Cause-specific mortality in long-term survivors of retinoblastoma.
Yu CL; Tucker MA; Abramson DH; Furukawa K; Seddon JM; Stovall M; Fraumeni JF; Kleinerman RA
J Natl Cancer Inst; 2009 Apr; 101(8):581-91. PubMed ID: 19351917
[TBL] [Abstract][Full Text] [Related]
56. Risk of Soft-Tissue Sarcoma Among 69 460 Five-Year Survivors of Childhood Cancer in Europe.
Bright CJ; Hawkins MM; Winter DL; Alessi D; Allodji RS; Bagnasco F; Bárdi E; Bautz A; Byrne J; Feijen EAM; Fidler MM; Garwicz S; Grabow D; Gudmundsdottir T; Guha J; Haddy N; Jankovic M; Kaatsch P; Kaiser M; Kuehni CE; Linge H; Øfstaas H; Ronckers CM; Skinner R; Teepen JC; Terenziani M; Vu-Bezin G; Wesenberg F; Wiebe T; Sacerdote C; Jakab Z; Haupt R; Lähteenmäki P; Zaletel LZ; Kuonen R; Winther JF; de Vathaire F; Kremer LC; Hjorth L; Reulen RC;
J Natl Cancer Inst; 2018 Jun; 110(6):649-660. PubMed ID: 29165710
[TBL] [Abstract][Full Text] [Related]
57. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries.
Olsen JH; Möller T; Anderson H; Langmark F; Sankila R; Tryggvadóttír L; Winther JF; Rechnitzer C; Jonmundsson G; Christensen J; Garwicz S
J Natl Cancer Inst; 2009 Jun; 101(11):806-13. PubMed ID: 19470947
[TBL] [Abstract][Full Text] [Related]
58. Risks of second malignancies after breast cancer treatment: Long-term results.
Bazire L; De Rycke Y; Asselain B; Fourquet A; Kirova YM
Cancer Radiother; 2017 Feb; 21(1):10-15. PubMed ID: 28034681
[TBL] [Abstract][Full Text] [Related]
59. Second cranio-facial malignancies in hereditary retinoblastoma survivors previously treated with radiation therapy: clinic and radiologic characteristics and survival outcomes.
Rodjan F; Graaf Pd; Brisse HJ; Verbeke JI; Sanchez E; Galluzzi P; Göricke S; Maeder P; Aerts I; Dendale R; Desjardins L; de Franscesco S; Bornfeld N; Sauerwein W; Popovic MB; Knol DL; Moll AC; Castelijns JA
Eur J Cancer; 2013 May; 49(8):1939-47. PubMed ID: 23415887
[TBL] [Abstract][Full Text] [Related]
60. Trilateral retinoblastoma: a systematic review and meta-analysis.
de Jong MC; Kors WA; de Graaf P; Castelijns JA; Kivelä T; Moll AC
Lancet Oncol; 2014 Sep; 15(10):1157-67. PubMed ID: 25126964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
